However as with the unmatched cohort, there was a numerical trend towards improved disease control in the ablation group (41% achieving and maintaining CR vs. 32%).
← all excerpts
Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study.
1
—
—